Ownership of individual-level health data, data sharing, and data governance

被引:16
|
作者
Piasecki, Jan [1 ]
Cheah, Phaik Yeong [2 ,3 ,4 ]
机构
[1] Jagiellonian Univ Med Coll, Fac Hlth Sci, Dept Philosophy & Bioeth, Kopernika 40, Krakow, Poland
[2] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, 420-6 Rajvithi Rd, Bangkok, Thailand
[3] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Old Rd Campus,Roosevelt Dr, Oxford, England
[4] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Oxford, England
基金
英国惠康基金;
关键词
Data ownership; Individual-level health data; Data access committees; Sharing data; Clinical trials; Research ethics; Learning healthcare system; Embedded research; Ethics; PRIVACY;
D O I
10.1186/s12910-022-00848-y
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Background The ownership status of individual-level health data affects the manner in which it is used. In this paper we analyze two competing models of the ownership status of the data discussed in the literature recently: private ownership and public ownership. Main body In this paper we describe the limitations of these two models of data ownership with respect to individual-level health data, in particular in terms of ethical principles of justice and autonomy, risk mitigation, as well as technological, economic, and conceptual issues. We argue that undifferentiated application of neither private ownership nor public ownership will allow us to resolve all the problems associated with effective, equitable, and ethical use of data. We suggest that, instead of focusing on data ownership, we should focus on the institutional and procedural aspects of data governance, such as using Data Access Committees (DACs) or equivalent managed access processes, which can balance the elements of these two ownership frameworks. Conclusion Undifferentiated application of the ownership concept (private or public) is not helpful in resolving problems associated with sharing individual-level health data. DACs or equivalent managed access processes should be an integral part of data governance. They can approve or disapprove data access requests after considering the potential benefits and harms to data subjects, their communities, primary researchers, and the wider society.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] City-scale synthetic individual-level vehicle trip data
    Li, Guilong
    Chen, Yixian
    Wang, Yimin
    Nie, Peilin
    Yu, Zhi
    He, Zhaocheng
    SCIENTIFIC DATA, 2023, 10 (01)
  • [42] Reply to: fMRI replicability depends upon sufficient individual-level data
    Turner, Benjamin O.
    Santander, Tyler
    Paul, Erick J.
    Barbey, Aron K.
    Miller, Michael B.
    COMMUNICATIONS BIOLOGY, 2019, 2 (1)
  • [43] Inverse probability weighted Cox model in multi-site studies without sharing individual-level data
    Shu, Di
    Yoshida, Kazuki
    Fireman, Bruce H.
    Toh, Sengwee
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2020, 29 (06) : 1668 - 1681
  • [44] USE OF INDIVIDUAL-LEVEL DATA TO INVESTIGATE GROUP PHENOMENA - ISSUES AND STRATEGIES
    HOYLE, RH
    CRAWFORD, AM
    SMALL GROUP RESEARCH, 1994, 25 (04) : 464 - 485
  • [45] On the Analysis of Hybrid Designs that Combine Group- and Individual-Level Data
    Smoot, E.
    Haneuse, S.
    BIOMETRICS, 2015, 71 (01) : 227 - 236
  • [46] DEB-tox and Data Gaps: Consequences for individual-level outputs
    Accolla, Chiara
    Vaugeois, Maxime
    Rueda-Cediel, Pamela
    Moore, Adrian
    Marques, Goncalo M.
    Marella, Purvaja
    Forbes, Valery E.
    ECOLOGICAL MODELLING, 2020, 431
  • [47] Reply to: fMRI replicability depends upon sufficient individual-level data
    Benjamin O. Turner
    Tyler Santander
    Erick J. Paul
    Aron K. Barbey
    Michael B. Miller
    Communications Biology, 2
  • [48] City-scale synthetic individual-level vehicle trip data
    Guilong Li
    Yixian Chen
    Yimin Wang
    Peilin Nie
    Zhi Yu
    Zhaocheng He
    Scientific Data, 10
  • [49] ASSESSING THE GENERALIZABILITY OF CLINICAL TRIALS WITHOUT INDIVIDUAL-LEVEL TRIAL DATA
    Wang, W. J.
    Bansal, A.
    Bennette, C.
    Basu, A.
    VALUE IN HEALTH, 2019, 22 : S322 - S323
  • [50] Current Practices in Missing Data Handling for Interrupted Time Series Studies Performed on Individual-Level Data: A Scoping Review in Health Research
    Bazo-Alvarez, Juan Carlos
    Morris, Tim P.
    Carpenter, James R.
    Petersen, Irene
    CLINICAL EPIDEMIOLOGY, 2021, 13 : 603 - 613